KFDA mulls BGMP guideline to ‘Joins’ generics

The Korea Food and Drug Administration is considering implementing the bulk good manufacturing practice to the generic versions of Joins, an arthritis drug developed by SK Chemicals Co.

In an information session on November 11, a KFDA official said the association will require Joins generic makers to submit BGMP dossiers covering GMP documents, matters concerning selection and management of ...